Cetuximab with irinotecan, folinic acid and 5-fluorouracil as first-line treatment in advanced gastroesophageal cancer: a prospective multi-center biomarker-oriented phase II study
Titel:
Cetuximab with irinotecan, folinic acid and 5-fluorouracil as first-line treatment in advanced gastroesophageal cancer: a prospective multi-center biomarker-oriented phase II study
Auteur:
Moehler, M. Mueller, A. Trarbach, T. Lordick, F. Seufferlein, T. Kubicka, S. Geißler, M. Schwarz, S. Galle, P.R. Kanzler, S.